Corporate Strategy Expertise

Whether you are just starting out or trying to evolve an established life science business, today’s investors are more aware than ever that sound strategy is essential. A mix of R&D productivity pressure, tightening regulations, scientific innovation and a market demanding value evidence is challenging companies to think carefully about their goals and priorities. Our life science consultants have rich experience in strategic planning with companies at all stages of corporate development.

  • Craft a business case for company strategy
  • Develop your corporate pitch deck for investors
  • Prioritize R&D spending through portfolio review and pipeline planning
  • Build a business unit or technology strategy plan

Case Studies

Commercial development plan for a mesenchymal stem cell therapy in acute GvHD

Challenge Our client was a leading UK Research Institute requiring assistance in assigning internal commercialisation funding to the most promising research groups within the University....

Commercial development plan for a CAR-T therapy in head and neck cancer

Challenge Our client was a leading UK Research Institute requiring assistance in assigning internal commercialisation funding to the most promising research groups within the University....

Commercial development plan for a CAR-T therapy in pancreatic ductal adenocarcinoma

Challenge Our client was a leading UK Research Institute requiring assistance in assigning internal commercialisation funding to the most promising research groups within the University....

Commercialisation roadmap for an RNA array

Challenge A leading UK University was developing an innovative technology to permit the creation of surface-immobilised functional RNAs in a microarray format, by transcription and...

Commercialisation roadmap for a new qPCR assay

Challenge A leading UK University was developing a ‘3-in-1’ PCR-based assay for rapid cell line verification and purity testing. The technology comprised a PCR-based assay containing novel...

Commercial planning for a rare oncology disease

Challenge A European Biotech company with its lead product being developed for a rare oncology disease in Phase 1 wanted to understand how to optimize and evaluate the commercial potential...